Cargando…
Inflammatory biomarkers of ischemic stroke
Ischemic stroke remains the second leading cause of death and among the major causes of morbidity worldwide. Therapeutic options are currently limited to early reperfusion strategies, while pharmacological neuroprotective strategies despite showing promising results in the experimental setting const...
Autores principales: | Tirandi, Amedeo, Sgura, Cosimo, Carbone, Federico, Montecucco, Fabrizio, Liberale, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082112/ https://www.ncbi.nlm.nih.gov/pubmed/36745280 http://dx.doi.org/10.1007/s11739-023-03201-2 |
Ejemplares similares
-
Predicting mortality in hospitalized COVID-19 patients
por: Tirandi, Amedeo, et al.
Publicado: (2022) -
The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions
por: Tirandi, Amedeo, et al.
Publicado: (2021) -
Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke
por: Bonaventura, Aldo, et al.
Publicado: (2016) -
Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management
por: Preda, Alberto, et al.
Publicado: (2023) -
Physical activity to reduce PCSK9 levels
por: Tirandi, Amedeo, et al.
Publicado: (2022)